Conference LibraryGated
Cancer Immunol Res 2026 · FAP-CAR via targeted LNP · lymphodepletion-free in vivo · Bajbouj/Puré
"Fibroblast activation protein (FAP), which is highly expressed on cancer-associated fibroblasts (CAF), is a promising therapeutic target to achieve normalization of the tumor microenvironment." In vivo strategy: "anti-CD5-conjugated targeted lipid nanoparticles (tLNP) encapsula…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_verify_wave_2_2026-05-16
- evidence_grade
- A
- category
- in_vivo_car_t_lnp_lymphodepletion_free
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "preclinical mouse model · NOT human clinical data · not intended to guide individual patient treatment choices"
- journal
- Cancer Immunology Research
- year
- 2026
- authors
- Khuloud Bajbouj,Ellen Puré
- abstract_snippet
- "Fibroblast activation protein (FAP), which is highly expressed on cancer-associated fibroblasts (CAF), is a promising therapeutic target to achieve normalization of the tumor microenvironment." In vivo strategy: "anti-CD5-conjugated targeted lipid nanoparticles (tLNP) encapsu
- pmid
- 41686204
- doi
- 10.1158/2326-6066.CIR-25-0663
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.